Compounds > naproxen
Page last updated: 2024-09-04

naproxen and Intestinal Diseases

naproxen has been researched along with Intestinal Diseases in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19902 (25.00)18.7374
1990's0 (0.00)18.2507
2000's3 (37.50)29.6817
2010's3 (37.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Horváth, Z; Kiss, G; Kovács, V; Rácz, I; Regőczi, H; Szalai, M1
Bercik, P; Blackler, RW; Manko, A; Motta, JP; Surette, MG; Wallace, JL; Workentine, M1
Bercik, P; Blackler, RW; Buret, AG; Da Silva, GJ; De Palma, G; Flannigan, KL; Manko, A; Surette, MG; Wallace, JL1
Bjarnason, I; Hotz-Behofsits, C; Sigthorsson, G; Simpson, R; Walley, M1
Scheiman, JM1
Takahira, Y; Takeuchi, K; Tanaka, A; Yokota, A1
Fujimura, H; Hidaka, T; Hiramatsu, Y; Hosoe, K; Watanabe, K; Yamashita, T1
Gyires, K; Hermecz, I; Knoll, J1

Trials

2 trial(s) available for naproxen and Intestinal Diseases

ArticleYear
Mucosal healing effect of mesalazine granules in naproxen-induced small bowel enteropathy.
    World journal of gastroenterology, 2013, Feb-14, Volume: 19, Issue:6

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Capsule Endoscopy; Female; Humans; Hungary; Intestinal Diseases; Intestinal Mucosa; Intestine, Small; Male; Mesalamine; Middle Aged; Naproxen; Pilot Projects; Severity of Illness Index; Time Factors; Treatment Outcome; Wound Healing

2013
What are the effects of cyclooxygenase-2-specific inhibitors on the small bowel?
    Nature clinical practice. Gastroenterology & hepatology, 2005, Volume: 2, Issue:5

    Topics: Adult; Celecoxib; Cyclooxygenase Inhibitors; Double-Blind Method; Drug Therapy, Combination; Follow-Up Studies; Humans; Intestinal Diseases; Intestinal Mucosa; Intestine, Small; Naproxen; Omeprazole; Prospective Studies; Pyrazoles; Sulfonamides

2005

Other Studies

6 other study(ies) available for naproxen and Intestinal Diseases

ArticleYear
Hydrogen sulphide protects against NSAID-enteropathy through modulation of bile and the microbiota.
    British journal of pharmacology, 2015, Volume: 172, Issue:4

    Topics: Alanine; Allyl Compounds; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bile; Cell Line; Cyclooxygenase 1; Gastrointestinal Hemorrhage; Humans; Hydrogen Sulfide; Intestinal Diseases; Intestinal Mucosa; Jejunum; Membrane Proteins; Microbiota; Naproxen; Protective Agents; Rats, Wistar; Sulfides; Ulcer

2015
Deciphering the pathogenesis of NSAID enteropathy using proton pump inhibitors and a hydrogen sulfide-releasing NSAID.
    American journal of physiology. Gastrointestinal and liver physiology, 2015, Jun-15, Volume: 308, Issue:12

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Hepatobiliary Elimination; Hydrogen Sulfide; Inflammation; Intestinal Diseases; Male; Naproxen; Proton Pump Inhibitors; Rats, Wistar; RNA, Ribosomal, 16S

2015
The effects of AZD3582 [4-(nitroxy)butyl-(2S)-2-(6-methoxy-2-naphthyl) propanoate], and naproxen on key pathogenic steps in NSAID-enteropathy in the rat.
    Inflammopharmacology, 2007, Volume: 15, Issue:3

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Enteritis; Intestinal Diseases; Male; Naproxen; Nitric Oxide Donors; Permeability; Rats; Rats, Sprague-Dawley; Ulcer

2007
Factors involved in upregulation of inducible nitric oxide synthase in rat small intestine following administration of nonsteroidal anti-inflammatory drugs.
    Digestive diseases and sciences, 2006, Volume: 51, Issue:7

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Diclofenac; Dinoprostone; Disease Models, Animal; Enterobacteriaceae; Flurbiprofen; Gastrointestinal Motility; Indomethacin; Intestinal Diseases; Intestinal Mucosa; Intestine, Small; Lactones; Male; Naproxen; Nitric Oxide; Nitric Oxide Synthase Type II; Pyrazoles; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sulfones; Time Factors; Up-Regulation

2006
Analgesic and anti-inflammatory activities in rats of alpha-(3,5-di-t-butyl-4-hydroxybenzylidene)-gamma-butyrolactone (KME-4), and its intestinal damage.
    The Journal of pharmacy and pharmacology, 1986, Volume: 38, Issue:10

    Topics: 4-Butyrolactone; Acetates; Acetic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Capillary Permeability; Edema; Furans; Ibuprofen; Indomethacin; Intestinal Diseases; Lethal Dose 50; Male; Naproxen; Rats; Rats, Inbred Strains

1986
1,6-Dimethyl-4-oxo-1,6,7,8,9,9a-hexahydro-4H-pyrido(1,2-a)- pyrimidine-3-carboxamide (Ch-127) protects against the intestinal damage in rats caused by two weeks' daily administration of indomethacin.
    Drugs under experimental and clinical research, 1987, Volume: 13, Issue:5

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Drug Combinations; Indomethacin; Intestinal Diseases; Male; Naproxen; Pyrimidinones; Rats; Rats, Inbred Strains; Ulcer

1987